Cargando…
The association between age and adverse events due to biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A retrospective cohort study
We examined whether the age of patients with rheumatoid arthritis was associated with adverse events (AEs) caused by biologic disease-modifying antirheumatic drugs (bDMARDs). Patients with rheumatoid arthritis using bDMARDs from Showa University Hospital, Showa University Northern Yokohama Hospital,...
Autores principales: | Ikari, Yuzo, Yajima, Nobuyuki, Miwa, Yusuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769304/ https://www.ncbi.nlm.nih.gov/pubmed/33350780 http://dx.doi.org/10.1097/MD.0000000000023861 |
Ejemplares similares
-
Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results
por: Armagan, Berkan, et al.
Publicado: (2018) -
Methotrexate can prevent cardiovascular events in patients with rheumatoid arthritis: An updated meta-analysis
por: Sun, Kai-jun, et al.
Publicado: (2021) -
Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry
por: Kim, Seong-Kyu, et al.
Publicado: (2020) -
Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment
por: Miwa, Yusuke, et al.
Publicado: (2017) -
Hypothyroidism risk associated with rheumatoid arthritis: A population-based retrospective cohort study
por: Huang, Chung-Ming, et al.
Publicado: (2022)